SKAN Group AG (XSWX:SKAN) Change In Receivables : CHF-8.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Change In Receivables?

SKAN Group AG's change in receivables for the quarter that ended in Dec. 2023 was CHF11.3 Mil. It means SKAN Group AG's Accounts Receivable declined by CHF11.3 Mil from Jun. 2023 to Dec. 2023 .

SKAN Group AG's change in receivables for the fiscal year that ended in Dec. 2023 was CHF-8.1 Mil. It means SKAN Group AG's Accounts Receivable increased by CHF8.1 Mil from Dec. 2022 to Dec. 2023 .

SKAN Group AG's Accounts Receivable for the quarter that ended in Dec. 2023 was CHF26.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SKAN Group AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 26.80.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SKAN Group AG's liquidation value for the six months ended in Dec. 2023 was CHF-33.1 Mil.

SKAN Group AG Change In Receivables Historical Data

The historical data trend for SKAN Group AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Change In Receivables Chart

SKAN Group AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-18.79

8.06

-2.37

-8.12

SKAN Group AG Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial			18.02	-2.92	0.55	-19.40	11.27

SKAN Group AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-8.1 Mil.

SKAN Group AG (XSWX:SKAN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SKAN Group AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	26.474	/	180.282	*	91
=	26.80

2. In Ben Graham's calculation of liquidation value, SKAN Group AG's accounts receivable are only considered to be worth 75% of book value:

SKAN Group AG's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	85.122	-	197.088	+	0.75 * 26.474	+	0.5 * 117.989
=	-33.1

SKAN Group AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

SKAN Group AG (XSWX:SKAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (XSWX:SKAN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SKANz:UK 0SKN:UK

Address

Kreuzstrasse 5, Allschwil, CHE, 4123

Website

https://www.skan.com

SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (XSWX:SKAN) Headlines

No Headlines